好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

An unusual relapse of Amyloid-Beta related Angiitis
Cerebrovascular Disease and Interventional Neurology
P1 - Poster Session 1 (8:00 AM-9:00 AM)
13-006
N/A
Inflammatory amyloid-β peptide deposition with cerebral amyloid angiopathy is a rare phenomenon described as Amyloid Beta-Related Angiitis (ABRA), leading to vessel fragility, microaneurysms, increased susceptibility to blood pressure fluctuations, small infarcts or microbleeds. We present a patient’s unusual disease progression over an extended period.

A 60-year-old woman presented with 3 weeks of headache and acute confusion, which resolved after intravenous hydration. She returned after a fall, drowsy, confused, weak on the left and aphasic. Work-up revealed elevated Sedimentation rate (34) and CRP (76). CSF had elevated protein (222), RBC (313), and corrected WBC (33). Vasculitis panel, serum and protein electrophoresis were unremarkable. 

She received broad spectrum antibiotics and steroids. MRI Brain demonstrated scattered foci of restricted diffusion in bilateral hemispheres in different vasculatures, left parietal vasogenic edema, and punctate areas of enhancement concerning for atypical PRES, thrombotic microangiopathy or inflammatory amyloid angiopathy.

Biopsy showed reactive gliosis, perivascular inflammation with multinucleated giant cells and fibrinoid necrosis of blood vessels. Congo red staining highlighted amyloid. ABRA was confirmed and prescribed high dose Prednisone with 10-week taper; patient recovered significantly but lost to follow up. 

A year later, she presented with seizure, hypothermia to 85 F and hypotension.  MRI Brain showed multifocal bilateral punctate infarcts, confluent vasogenic edema in frontal, temporal, and left parieto-occipital lobes, with extensive microbleeds along subcortical-cortical margins. Arteriogram was unremarkable. Treatment with antibiotics, and daily intravenous Methylprednisone was started. By day 3, the patient was off vasopressor, transitioned to oral prednisone and started cyclophosphamide. She returned to baseline mentation and strength on 2 month follow up.


N/A

ABRA is an increasingly recognized clinical condition in the elderly that commonly present with seizures, cognitive symptoms and headaches. Coma and autonomic instability is a rare presentation, and histopathological confirmation can dramatically alter the course of this often reversible condition.


Authors/Disclosures
Lamya Ibrahim, MD, MBBS (Hospital of the University of Pennsylvania)
PRESENTER
Dr. Ibrahim has nothing to disclose.
Grant Meeks, MD (University of Texas Health Science Center at Houston) Mr. Meeks has nothing to disclose.
Ashley Streseman, MD (UTHEALTH Houston) Dr. Streseman has nothing to disclose.
Muhammad Bilal Tariq, MBBS (UT health Science Center at Houston) Dr. Tariq has nothing to disclose.
Meenakshi Bhattacharjee (UTHSC- Houston) No disclosure on file
Sean I. Savitz, MD Dr. Savitz has nothing to disclose.